focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.675
Bid: 1.65
Ask: 1.70
Change: 0.025 (1.52%)
Spread: 0.05 (3.03%)
Open: 1.65
High: 1.95
Low: 1.65
Prev. Close: 1.65
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: iEnergizer to depart; Unbound for sale

Fri, 19th May 2023 10:15

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

iEnergizer PLC, up 24% at 67 pence, 12-month range 29.5p-526p. The Noida, India-based IT service management firm says its shares will stop trading on AIM on Wednesday. In April, it said it was seeking cancellation, stating that staying on the stock exchange was "unlikely to provide the company with significantly wider access to capital", adding that the cost and legal implications of maintaining its admission to trading on AIM were "disproportionate" to the benefits.

----------

Genedrive PLC, up 16% at 23.70p, 12-month range 8.00p-48.86p. The point-of-care molecular diagnostics firm says the UK National Institute for Health & Care Excellence recommends in draft guidance that CYP2C19 genotyping should be used before clopidogrel administration in managing ischemic stroke patients. "Screening patients to assess their clopidogrel resistance status allows for alternative treatments and better clinical outcomes," the company explains. The NICE Committee included the firm's CYP2C19 ID test in its review. Genedrive notes the test is still in development. Awaits the UKCA marking on the test prior to NICE's final report, currently scheduled for October.

----------

AIM - LOSERS

----------

Velocys PLC, down 28% at 2.41p, 12-month range 2.20p-7.30p. The sustainable fuels technology company says the books are covered at around GBP6 million for its placing and retail offer. The books remain open. The fundraise was announced after the market close on Thursday, with an issue price of 2.5p for each. The price is a 26% discount to Thursday's closing price of 3.4p. Velocys had voiced concerns over its ability to continue as a going concern. It aims to raise at least GBP32 million by the placing, retail offer, open offer, as well as a conditional issuance of convertible loan notes to Carbon Direct Capital and potential further issuances of convertible loan notes and/or new ordinary shares to investors other than Carbon Direct Capital.

----------

Unbound Group PLC, down 23% at 2.51p, 12-month range 2.51p-35.94p. The stock reaches a 12-month low as the firm launches a strategic review, including a formal sales process. Unbound is the parent company for a retail group selling a range of brands focused on the 55+ demographic, including Hotter Shoes. The review is to explore its strategic options, and could include a full sale of the company. Unbound warns a temporary working capital shortfall could arise in September and October this year. It continues to work with its advisers and banking partners to raise additional funds or refinance its current facilities.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
25 Mar 2021 11:28

AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook

AIM WINNERS & LOSERS: Tandem rises on strong results, positive outlook

Read more
18 Mar 2021 16:06

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Mar 2021 14:34

IN BRIEF: Genedrive to distribute pathogen detection assays in US

IN BRIEF: Genedrive to distribute pathogen detection assays in US

Read more
3 Mar 2021 21:53

TRADING UPDATES: Team PLC prices IPO; Nostra's Cypress doubles

TRADING UPDATES: Team PLC prices IPO; Nostra's Cypress doubles

Read more
17 Feb 2021 11:27

AIM WINNERS & LOSERS: Blockchain Stocks Rise As Bitcoin Hits New High

AIM WINNERS & LOSERS: Blockchain Stocks Rise As Bitcoin Hits New High

Read more
17 Feb 2021 09:32

Genedrive Makes First Shipments Of SARS-CoV-2 Test Kits To US

Genedrive Makes First Shipments Of SARS-CoV-2 Test Kits To US

Read more
28 Jan 2021 14:26

IN BRIEF: Genedrive Soars After Sealing PCR Test Distribution Deal

IN BRIEF: Genedrive Soars After Sealing PCR Test Distribution Deal

Read more
28 Jan 2021 10:22

AIM WINNERS & LOSERS: Eurasia Rallies As It Explains Churakov Sale

AIM WINNERS & LOSERS: Eurasia Rallies As It Explains Churakov Sale

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
16 Dec 2020 12:16

Genedrive notifies FDA of intent to distribute Covid test

(Sharecast News) - Molecular diagnostics company Genedrive has notified the United States Food and Drug Association (FDA) of its intention to import and distribute its 'Genedrive 96 SARS-CoV-2 Kit' prior to an emergency use authorisation (EUA) determination, it announced on Wednesday.

Read more
16 Dec 2020 11:04

IN BRIEF: Genedrive To Commence Covid Testing Kit Distribution In US

IN BRIEF: Genedrive To Commence Covid Testing Kit Distribution In US

Read more
11 Dec 2020 19:34

IN BRIEF: Genedrive To Issue Shares To BGF After Loan Note Conversion

IN BRIEF: Genedrive To Issue Shares To BGF After Loan Note Conversion

Read more
3 Dec 2020 19:58

UK TRADING UPDATE SUMMARY: BMO Commercial Free From Arcadia, Debenhams

UK TRADING UPDATE SUMMARY: BMO Commercial Free From Arcadia, Debenhams

Read more
20 Nov 2020 19:26

IN BRIEF: Genedrive's HCV ID Kit Deemed Suitable For Use In India

IN BRIEF: Genedrive's HCV ID Kit Deemed Suitable For Use In India

Read more
17 Nov 2020 14:49

UK EARNINGS SUMMARY: Focusrite Revenue Up Over 50% On Acquisitions

UK EARNINGS SUMMARY: Focusrite Revenue Up Over 50% On Acquisitions

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.